Introducing functional proteomics: A new solution for precision medicine. This white paper unravels how IsoPlexis meets the challenges in oncology head-on, from untangling drug tolerance trajectories to steering targeted therapies and thwarting metastasis. The IsoPlexis product suite, featuring single-cell intracellular proteome, metabolome, and secretome solutions, takes center stage in this transformative approach.
Download the white paper to discover:
Independent pathways to drug tolerance in tumors by using the IsoPlexis product suite
How genomic analysis can be applied to mitigate critical problems like tumor metastasis
How to apply single-cell secretome technology to cytokine profiling